Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
在代谢功能障碍相关脂肪肝疾病的小鼠模型中,elobixibat 与 colestyramine 联合用药可降低胆固醇毒性。
期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000285
Iwaki, Michihiro; Kessoku, Takaomi; Tanaka, Kosuke; Ozaki, Anna; Kasai, Yuki; Kobayashi, Takashi; Nogami, Asako; Honda, Yasushi; Ogawa, Yuji; Imajo, Kento; Usuda, Haruki; Wada, Koichiro; Kobayashi, Noritoshi; Saito, Satoru; Nakajima, Atsushi; Yoneda, Masato